Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $48,987 | 2,175 | 99.8% |
| Education | $102.04 | 21 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $6,273 | 252 | $0 (2024) |
| Novo Nordisk Inc | $4,322 | 209 | $0 (2024) |
| ABBVIE INC. | $4,296 | 218 | $0 (2024) |
| Lilly USA, LLC | $3,781 | 189 | $0 (2024) |
| GlaxoSmithKline, LLC. | $3,546 | 123 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $3,171 | 98 | $0 (2024) |
| Amgen Inc. | $3,026 | 147 | $0 (2024) |
| Allergan, Inc. | $2,534 | 149 | $0 (2020) |
| PFIZER INC. | $2,389 | 105 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,932 | 72 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,861 | 215 | AstraZeneca Pharmaceuticals LP ($1,155) |
| 2023 | $5,262 | 211 | AstraZeneca Pharmaceuticals LP ($881.81) |
| 2022 | $5,044 | 264 | ABBVIE INC. ($903.31) |
| 2021 | $8,739 | 349 | AbbVie Inc. ($1,564) |
| 2020 | $5,127 | 260 | AstraZeneca Pharmaceuticals LP ($626.00) |
| 2019 | $6,866 | 282 | Allergan Inc. ($862.20) |
| 2018 | $6,001 | 286 | Boehringer Ingelheim Pharmaceuticals, Inc. ($638.47) |
| 2017 | $6,189 | 329 | Boehringer Ingelheim Pharmaceuticals, Inc. ($687.35) |
All Payment Transactions
2,196 individual payment records from CMS Open Payments — Page 1 of 88
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Diabetes | ||||||
| 12/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: Biological | ||||||
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: DIABETES | ||||||
| 12/17/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Insomnia | ||||||
| 12/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: PAIN | ||||||
| 12/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: Respiratory | ||||||
| 11/27/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $34.90 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/25/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $22.58 | General |
| 11/18/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $1.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Inflammation | ||||||
| 11/08/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $20.82 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.78 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $0.87 | General |
| Category: Cardio-renal | ||||||
| 10/29/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $122.55 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.76 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 927 | 1,632 | $198,874 | $144,504 |
| 2022 | 15 | 967 | 1,676 | $204,599 | $136,411 |
| 2021 | 16 | 1,123 | 2,073 | $250,930 | $172,610 |
| 2020 | 17 | 1,379 | 2,540 | $270,315 | $166,965 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 162 | 457 | $66,265 | $46,019 | 69.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 112 | 235 | $44,650 | $33,319 | 74.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 149 | 401 | $36,090 | $26,905 | 74.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 162 | 162 | $23,435 | $21,078 | 89.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 21 | 21 | $5,250 | $4,084 | 77.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 20 | 20 | $4,180 | $3,364 | 80.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 168 | 168 | $3,864 | $3,111 | 80.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 16 | 18 | $8,712 | $2,967 | 34.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $4,100 | $2,723 | 66.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 31 | 38 | $988.00 | $438.03 | 44.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 28 | 35 | $350.00 | $294.00 | 84.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 23 | 42 | $840.00 | $143.22 | 17.1% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 15 | 15 | $150.00 | $59.10 | 39.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 173 | 465 | $67,425 | $43,260 | 64.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 127 | 254 | $48,260 | $33,756 | 69.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 165 | 401 | $36,090 | $23,483 | 65.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 156 | 156 | $22,762 | $20,800 | 91.4% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 24 | 26 | $12,584 | $4,067 | 32.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 162 | 162 | $3,726 | $3,040 | 81.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 14 | 14 | $3,500 | $2,756 | 78.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 14 | 14 | $2,926 | $2,413 | 82.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $3,280 | $1,306 | 39.8% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 12 | 14 | $1,008 | $567.14 | 56.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 13 | 39 | $1,248 | $434.27 | 34.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 19 | 25 | $650.00 | $286.56 | 44.1% |
About Ricardo Marques
Ricardo Marques is a Internal Medicine healthcare provider based in Boca Raton, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811957749.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ricardo Marques has received a total of $49,089 in payments from pharmaceutical and medical device companies, with $5,861 received in 2024. These payments were reported across 2,196 transactions from 83 companies. The most common payment nature is "Food and Beverage" ($48,987).
As a Medicare-enrolled provider, Marques has provided services to 4,396 Medicare beneficiaries, totaling 7,921 services with total Medicare billing of $620,491. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Boca Raton, FL
- Active Since 03/24/2006
- Last Updated 10/27/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1811957749
Products in Payments
- JARDIANCE (Drug) $2,790
- VRAYLAR (Drug) $2,570
- FARXIGA (Drug) $2,270
- TRELEGY ELLIPTA (Drug) $2,089
- NURTEC ODT (Drug) $2,047
- BREZTRI (Drug) $1,893
- UBRELVY (Drug) $1,734
- Aimovig (Biological) $1,333
- TRULICITY (Drug) $1,320
- Ozempic (Drug) $1,315
- Vascepa (Drug) $1,163
- Otezla (Drug) $1,054
- XARELTO (Drug) $990.00
- Wegovy (Drug) $794.78
- MOUNJARO (Drug) $792.48
- ENTRESTO (Drug) $733.07
- Saxenda (Drug) $645.96
- Tresiba (Drug) $615.22
- TOUJEO (Drug) $583.00
- SYMBICORT (Drug) $580.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Boca Raton
Dr. Stephen Milan, M.d, M.D
Internal Medicine — Payments: $86,912
Brian Moraes, Do, DO
Internal Medicine — Payments: $34,621
Dr. Heather Johnson, M.d, M.D
Internal Medicine — Payments: $29,015
Michael Cammarata, Md, MD
Internal Medicine — Payments: $17,985
Dr. Eli Levine, M.d, M.D
Internal Medicine — Payments: $15,837
Dr. Gladys Martinez, Do, DO
Internal Medicine — Payments: $14,353